+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Bromides 1810-71-5
1810-71-5,MFCD04115272
Catalog No.:AA0022GS

1810-71-5 | 6-Bromo-2-chloroquinoline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$11.00   $8.00
- +
5g
98%
in stock  
$35.00   $25.00
- +
10g
98%
in stock  
$66.00   $47.00
- +
100g
98%
in stock  
$540.00   $378.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0022GS
Chemical Name:
6-Bromo-2-chloroquinoline
CAS Number:
1810-71-5
Molecular Formula:
C9H5BrClN
Molecular Weight:
242.4997
MDL Number:
MFCD04115272
SMILES:
Brc1ccc2c(c1)ccc(n2)Cl
Properties
Properties
 
BP:
325.7°C at 760 mmHg  
Form:
Solid  
MP:
165 °C  
Solubility:
Soluble in Chloroform and Methanol  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
165  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
1  
XLogP3:
3.4  

Upstream Synthesis Route

[1]Patent:WO2017/46739,2017,A1,.Locationinpatent:Page/Pagecolumn78

[2]JournaloftheAmericanChemicalSociety,2016,vol.138,#25,p.7808-7811

[3]Patent:WO2006/132739,2006,A2,.Locationinpatent:Page/Pagecolumn36

[4]EuropeanJournalofMedicinalChemistry,2000,vol.35,#10,p.931-940

[5]Patent:WO2009/39127,2009,A1,.Locationinpatent:Page/Pagecolumn181

[6]Patent:WO2009/39134,2009,A1,.Locationinpatent:Page/Pagecolumn110

[7]BioorganicandMedicinalChemistryLetters,2006,vol.16,#22,p.5907-5912

[8]Patent:WO2005/75428,2005,A1,.Locationinpatent:Page/Pagecolumn31-32

[9]Patent:WO2007/14941,2007,A2,.Locationinpatent:Page/Pagecolumn36-37

[10]JournalofMedicinalChemistry,1988,vol.31,#10,p.2048-2056

[11]BioorganicandMedicinalChemistryLetters,1999,vol.9,#18,p.2753-2758

[12]Patent:WO2004/24731,2004,A1,.Locationinpatent:Page50

[13]ChemicalandPharmaceuticalBulletin,2014,vol.62,#6,p.508-518

[14]Patent:WO2015/96035,2015,A1,.Locationinpatent:Page/Pagecolumn53;54

[15]Patent:WO2015/100147,2015,A1,.Locationinpatent:Page/Pagecolumn54

[1]EuropeanJournalofOrganicChemistry,2016,vol.2016,#8,p.1606-1611

[2]TetrahedronLetters,2014,vol.55,#51,p.7130-7132

[3]Patent:WO2009/155527,2009,A2,.Locationinpatent:Page/Pagecolumn132

[1]EuropeanJournalofMedicinalChemistry,2000,vol.35,#10,p.931-940

[2]Patent:US6034093,2000,A,

[3]Patent:US5731315,1998,A,

[4]Patent:WO2006/132739,2006,A2,

[1]BioorganicandMedicinalChemistryLetters,2000,vol.10,#14,p.1559-1562

[1]EuropeanJournalofOrganicChemistry,2016,vol.2016,#8,p.1606-1611

[2]Patent:WO2009/155527,2009,A2,

Downstream Synthesis Route

[1]CurrentPatentAssignee:ROTTAPHARMBIOTECHS.R.L.-WO2009/152868,2009,A1Locationinpatent:Page/Pagecolumn42

[2]Kim,Younghee;Son,Jiwon;Kim,Juhyeon;Baek,Du-Jong;Lee,YongSup;Lim,EunJeong;Lee,JaeKyun;Pae,AeNim;Min,Sun-Joon;Cho,YongSeo[ChemicalandPharmaceuticalBulletin,2014,vol.62,#6,p.508-518]

[3]Alabaster;Bell;Campbell;Ellis;Henderson;Roberts;Ruddock;Samuels;Stefaniak[JournalofMedicinalChemistry,1988,vol.31,#10,p.2048-2056]

[4]CurrentPatentAssignee:INFINITYPHARMACEUTICALSINC-US2015/368278,2015,A1Locationinpatent:Paragraph1019

[1]ACSMedicinalChemistryLetters,2019,vol.10,p.1380-1385

[2]Patent:WO2017/46739,2017,A1.Locationinpatent:Page/Pagecolumn78

[3]JournaloftheAmericanChemicalSociety,2016,vol.138,p.7808-7811

[4]Patent:WO2006/132739,2006,A2.Locationinpatent:Page/Pagecolumn36

[5]EuropeanJournalofMedicinalChemistry,2000,vol.35,p.931-940

[6]Patent:WO2009/39127,2009,A1.Locationinpatent:Page/Pagecolumn181

[7]Patent:WO2009/39134,2009,A1.Locationinpatent:Page/Pagecolumn110

[8]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.5907-5912

[9]Patent:WO2005/75428,2005,A1.Locationinpatent:Page/Pagecolumn31-32

[10]Patent:WO2007/14941,2007,A2.Locationinpatent:Page/Pagecolumn36-37

[11]JournalofMedicinalChemistry,1988,vol.31,p.2048-2056

[12]BioorganicandMedicinalChemistryLetters,1999,vol.9,p.2753-2758

[13]Patent:WO2004/24731,2004,A1.Locationinpatent:Page50

[14]ChemicalandPharmaceuticalBulletin,2014,vol.62,p.508-518

[15]Patent:WO2015/96035,2015,A1.Locationinpatent:Page/Pagecolumn53;54

[16]Patent:WO2015/100147,2015,A1.Locationinpatent:Page/Pagecolumn54

[1]Lee,ByoungSe;Chu,Soyoung;Lee,ByungChul;Chi,DaeYoon;Choe,YearnSeong;Jeong,KyungJa;Jin,Changbae[BioorganicandMedicinalChemistryLetters,2000,vol.10,#14,p.1559-1562]

[1]Baston,Eckhard;Palusczak,Anja;Hartmann,RolfW.[EuropeanJournalofMedicinalChemistry,2000,vol.35,#10,p.931-940]

[2]CurrentPatentAssignee:LANTHEUSMIHOLDINGSINC-WO2009/155527,2009,A2Locationinpatent:Page/Pagecolumn132

[3]CurrentPatentAssignee:SAINTLOUISUNIVERSITY-WO2020/132004,2020,A1Locationinpatent:Page/Pagecolumn309

[1]Patent:WO2009/39127,2009,A1.Locationinpatent:Page/Pagecolumn181

[2]Patent:WO2009/39134,2009,A1.Locationinpatent:Page/Pagecolumn110

[3]Patent:WO2021/13910,2021,A1.Locationinpatent:Page/Pagecolumn46

[4]JournalofMedicinalChemistry,2004,vol.47,p.5405-5417

[5]JournalofMedicinalChemistry,2011,vol.54,p.5836-5857

[6]Patent:WO2018/237370,2018,A1

Literature

Title: Sequential and selective Buchwald-Hartwig amination reactions for the controlled functionalization of 6-bromo-2-chloroquinoline: synthesis of ligands for the Tec Src homology 3 domain.

Journal: The Journal of organic chemistry 20081121

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1810-71-5
101870-60-4

101870-60-4

 1233025-78-9

1233025-78-9

 1245647-25-9

1245647-25-9

 1307316-83-1

1307316-83-1

 163485-86-7

163485-86-7

 205055-63-6

205055-63-6
Building Blocks
More >
Tags:1810-71-5 Molecular Formula|1810-71-5 MDL|1810-71-5 SMILES|1810-71-5 6-Bromo-2-chloroquinoline |Organic_Building_Blocks